For more information on how our historical price data is adjusted see the '>Stock Price Adjustment Guide. Pacific Biosciences of C... (PACB) stock price, charts, trades & the US's most popular discussion forums. Pacific Biosciences of California has a beta of 1.7, indicating that its stock price is 70% more volatile than the S&P 500. View Pacific Biosciences of California, Inc. PACB investment & stock information. Free forex prices, toplists, indices and lots more. Pacific Biosciences of California Stock Price Forecast, PACB stock price prediction. Approximately 2,311,252 shares traded hands during trading, a decline of 14% from the average daily volume of 2,682,168 shares. Pacific Biosciences also granted the underwriters a 30-day option to purchase up to an additional 914,416 shares of its common stock at the public offering price, less … Real time Pacific Biosciences of California (PACB) stock price quote, stock graph, news & analysis. The Pacific Biosciences of California stock price fell by -3.62% on the last day (Friday, 11th Dec 2020) from $21.94 to $21.15. Pacific Biosciences of California, Inc. COMMON STOCK ... On November 9, 2020, the last reported sale price for our common stock on The Nasdaq Global Select Market was $14.85 per share. View real-time stock prices and stock quotes for a full financial overview. We find that current price change of -1.16% and +278.62% over the past 12 months for PACB competes that of Thermo Fisher Scientific Inc (TMO), which has seen its stock price fall -0.9% in the last trading session and was +45.75% over the last one year. MENLO PARK, Calif. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of 19,430,000 shares of its common stock at a price … The Pacific Biosciences of California stock price gained 6.12% on the last trading day (Friday, 27th Nov 2020), rising from $14.54 to $15.43. The stock's open price was 6.51. The summary for PACIFIC BIOSCIENCES CALIFORNIA INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. The stock had previously closed at $14.54. Price to trailing twelve month operating cash flow for PACB is currently 253.68, higher than 98.39% of US stocks with positive operating cash flow. The stock’s price range for the 52-week period managed to maintain the … PACB Stock Summary. Pacific Biosciences of California, Inc. (NASDAQ:PACB) hit a new 52-week high during mid-day trading on Monday . During the day the stock fluctuated 5.68% from a day low at $21.05 to a day high of $22.25. On Friday Pacific Biosciences of California stock price gained impressive 6.12% (Updated on November 27, 2020) Buy or Hold candidate since 2020-08-03 Gain 294.63% PDF . In depth view into PACB (Pacific Biosciences of California) stock including the latest price, news, dividend history, earnings information and financials. Here is what Baron Discovery Fund said: Here is … Pacific Biosciences of California is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks. SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, … The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.57, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 50.62. Get the latest information on Pacific Biosciences of California stock (NASDAQ: PACB), including a real-time stock price quote, news, financials, charts and more. The price has risen in 8 of the last 10 days and is up by 37.04% over the past 2 weeks. X. The stock had previously closed at $20.18. View today's stock price, news and analysis for Pacific Biosciences of California Inc. (PACB). The historical data and Price History for Pacific Biosciences (PACB) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s stock price rose 6.1% during mid-day trading on Friday . Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics. Pacific Biosciences of California, Inc. Year-to-date, Pacific Biosciences Of California Inc. (NASDAQ:PACB) stock gained 250.2% and on December 2nd it had a closing price of $18.00. Risk & Volatility. The stock traded as high as $15.63 and last traded at $15.43. Investors use this metric to determine how a company's stock price stacks up to its intrinsic value. The stock traded as high as $21.90 and last traded at $21.36, with a volume of 9767 shares traded. Get Pacific Biosciences of California, Inc.'s stock price today. The current P/S ratio for Pacific Biosciences Of California as of November 13, 2020 is . PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. PACB stock quote, chart and news. Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news and financial information from CNBC. Read More It operates through the following geographical segments: North America, Europe, and Asia Pacific. Historical PS ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. Let’s briefly compare Pacific Biosciences of California, Inc. (PACB) stock to its peers. The listed name for PACB is Pacific Biosciences of California, Inc. Common Stock. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. Based on 4 analysts offering 12 month price targets for Pacific Biosciences in the last 3 months. Price target in 14 days: 28.116 USD. With a price/sales ratio of 49.62, Pacific Biosciences Of California Inc has a higher such ratio than 95.33% of stocks in our set. Announces Proposed Public Offering of Common Stock MarketWatch 11/10/2020 Pacific Biosciences of California, … Presently, Pacific Biosciences of California Inc. shares are logging 6.28% during the 52-week period from high price, and 877.27% higher than the lowest price point for the same timeframe. Pacific Biosciences is trading at 6.80 as of the 9th of September 2020, which is a 4.45 percent increase since the beginning of the trading day. The average price target is $16.00 with a high forecast of $25.00 and a low forecast of $12.00.The average price target represents a -24.33% decrease from the last price of $21.15. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Find the latest Revenue & EPS data for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.